MedVector Unveils Prime-Control Technology to Expand Subject Enrollment in Clinical Trials

MedVector introduces its Prime-Controltm Technology to provide contract research organizations and pharmaceutical sponsors with access to subjects for new clinical trials. FREMONT, CA: MedVector has begun a nationwide rollout of its Prime-Controltm Technology, which will provide contract research organizations (CROs) and pharmaceutical sponsors with access to numerous patients without the requirement of new clinical trial sites.…

MedVector Launches its Prime-Control Technology to Expand Subject Enrollment Beyond Clinical Trial Sites

March 25, 2021 – MedVector has begun the rollout of its Prime-Controltm Technology, to give contract research organizations (CROs) and pharma sponsors access to patients without triggering new clinical trial sites. MedVector is the only company that partners with CROs, sponsors, and patient recruitment companies to expand subject participation beyond existing clinical trial sites. Clinical…